What laboratory tests are requested for a patient suspected of having cholangitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Tests for Suspected Cholangitis

For patients with suspected acute cholangitis, order the following laboratory tests: complete blood count with differential, C-reactive protein, comprehensive metabolic panel including total and direct bilirubin, alkaline phosphatase, aminotransferases (ALT/AST), albumin, and prothrombin time. 1, 2

Essential Laboratory Markers

Inflammatory Markers

  • White blood cell count (WBC) - typically shows leukocytosis indicating systemic infection 1, 3, 2
  • C-reactive protein (CRP) - levels >75 mg/L support the diagnosis of acute cholangitis 1
  • These markers help distinguish infectious cholangitis from other causes of biliary obstruction 1, 2

Cholestatic Markers

  • Alkaline phosphatase (ALP) - the most common biochemical abnormality in cholangitis, typically elevated 1, 4
  • Total and direct bilirubin - elevation >2× upper limit of normal indicates biliary stasis; fractionation helps confirm hepatobiliary origin 5, 1, 2
  • Gamma-glutamyltransferase (GGT) - confirms hepatobiliary origin of elevated ALP 5
  • Aminotransferases (ALT/AST) - typically elevated but less prominently than ALP 1, 2

Hepatic Synthetic Function

  • Albumin - assesses hepatic synthetic function and helps with risk stratification 5
  • Prothrombin time/INR - evaluates coagulation status and liver function 5
  • Platelet count - important for risk assessment and may indicate advanced liver disease 5

Clinical Context and Pitfalls

The combination of fever/chills, right upper quadrant pain, and jaundice (Charcot's triad) is now seen less frequently than historically described, particularly in patients with indwelling biliary tubes or after biliary manipulation 3, 2. However, laboratory abnormalities remain consistently present 3, 4.

Important caveat: Patients with indwelling biliary tubes may develop cholangitis without significant jaundice, making inflammatory markers (WBC, CRP) particularly important in this population 3.

Additional Considerations for Specific Scenarios

When Sclerosing Cholangitis is in the Differential

  • Serum IgG4 levels - should be tested at screening to identify IgG4-related cholangitis 5
  • Antinuclear antibody (ANA) and anti-smooth muscle antibody - establish baseline to evaluate for overlap syndrome with autoimmune hepatitis 5
  • IgG levels - elevated in autoimmune hepatitis overlap 5

For Severity Grading

Laboratory markers help classify cholangitis severity according to Tokyo Guidelines: severe (Grade III) cholangitis includes organ dysfunction markers such as creatinine >2.0 mg/dL (renal dysfunction) or evidence of cardiovascular dysfunction requiring vasopressors 1, 2.

Diagnostic Algorithm Integration

These laboratory tests should be obtained alongside abdominal ultrasound as the initial imaging modality 1, 6. The diagnosis requires clinical signs (fever, abdominal pain, jaundice), laboratory findings indicating inflammation and biliary stasis, and imaging evidence of biliary dilatation or obstruction 1, 2.

References

Guideline

Diagnóstico y Clasificación de Colangitis Aguda

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines.

Journal of hepato-biliary-pancreatic surgery, 2007

Research

Acute cholangitis.

The Surgical clinics of North America, 1990

Research

Acute (ascending) cholangitis.

Infectious disease clinics of North America, 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Transabdominal Ultrasound as First-Line Imaging for Acute Cholangitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.